About STAAR Surgical Company (NASDAQ:STAA)
STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). As of December 30, 2016, it sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Equipment, Supplies & Distribution
- Sub-Industry: Health Care Supplies
- Symbol: NASDAQ:STAA
- CUSIP: 85231230
- Web: www.staar.com
- Market Cap: $532.36 million
- Outstanding Shares: 41,108,000
- 50 Day Moving Avg: $12.39
- 200 Day Moving Avg: $10.77
- 52 Week Range: $7.46 - $13.95
Sales & Book Value:
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: 68.16
- P/E Growth: -4.53
- Annual Revenue: $84.48 million
- Price / Sales: 6.30
- Book Value: $0.93 per share
- Price / Book: 13.92
- EBITDA: ($672,999.00)
- Net Margins: -6.06%
- Return on Equity: -8.69%
- Return on Assets: -5.03%
- Debt-to-Equity Ratio: 0.03%
- Current Ratio: 2.52%
- Quick Ratio: 1.81%
- Average Volume: 92,860 shs.
- Beta: 1.18
- Short Ratio: 31.08
Frequently Asked Questions for STAAR Surgical Company (NASDAQ:STAA)
What is STAAR Surgical Company's stock symbol?
STAAR Surgical Company trades on the NASDAQ under the ticker symbol "STAA."
How were STAAR Surgical Company's earnings last quarter?
STAAR Surgical Company (NASDAQ:STAA) released its earnings results on Wednesday, August, 2nd. The company reported ($0.01) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.05) by $0.04. The company had revenue of $21.90 million for the quarter, compared to analysts' expectations of $22.15 million. STAAR Surgical Company had a negative return on equity of 8.69% and a negative net margin of 6.06%. The business's revenue for the quarter was up 4.8% on a year-over-year basis. During the same quarter in the previous year, the business posted ($0.02) EPS. View STAAR Surgical Company's Earnings History.
When will STAAR Surgical Company make its next earnings announcement?
Where is STAAR Surgical Company's stock going? Where will STAAR Surgical Company's stock price be in 2017?
2 analysts have issued 1 year target prices for STAAR Surgical Company's shares. Their predictions range from $15.00 to $15.00. On average, they anticipate STAAR Surgical Company's share price to reach $15.00 in the next twelve months. View Analyst Ratings for STAAR Surgical Company.
Who are some of STAAR Surgical Company's key competitors?
Some companies that are related to STAAR Surgical Company include Orthofix International N.V. (OFIX), Intersect ENT (XENT), Cardiovascular Systems (CSII), K2M Group Holdings (KTWO), AtriCure (ATRC), CryoLife (CRY), Meridian Bioscience (VIVO), Landauer (LDR), Consort Medical plc (CSRT), Transenterix (TRXC), Transenterix (TRXC), Invacare Corporation (IVC), Exactech (EXAC), Antares Pharma (ATRS), Sientra (SIEN), Utah Medical Products (UTMD), Ocular Therapeutix (OCUL) and T2 Biosystems (TTOO).
Who are STAAR Surgical Company's key executives?
STAAR Surgical Company's management team includes the folowing people:
- Caren L. Mason, President, Chief Executive Officer, Director
- Deborah J. Andrews, Chief Financial Officer, Vice President
- Hans-Martin Blickensdoerfer, Senior Vice President - Commercial Operations for Europe, Middle East, Africa, Latin America and China.
- James E. Francese, Senior Vice President of North American and APAC
- Keith Holliday Ph.D., Chief Technology Officer, Vice President
- Surindra Mann, Vice President - Global Financial Planning and Analysis
- William Walter Goodmen, Vice President - Global Human Resources
- Jon K. Hayashida, Vice President - Global Clinical and Medical Affairs
- Philippe Subrin, Vice President-ICL Manufacturing
- Samuel J. Gesten, Vice President - Business Development, Chief Legal Officer and Secretary
How do I buy STAAR Surgical Company stock?
Shares of STAAR Surgical Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is STAAR Surgical Company's stock price today?
MarketBeat Community Rating for STAAR Surgical Company (NASDAQ STAA)MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
One share of STAAR Surgical Company stock can currently be purchased for approximately $12.95.
Earnings History for STAAR Surgical Company (NASDAQ:STAA)Earnings History by Quarter for STAAR Surgical Company (NASDAQ STAA)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/2/2017||Q2 2017||($0.05)||($0.01)||$22.15 million||$21.90 million||View||Listen|
|5/3/2017||Q1 2017||($0.05)||($0.05)||$20.35 million||View||Listen|
|3/2/2017||Q4 2016||($0.02)||$0.02||$22.25 million||$22.10 million||View||Listen|
|11/3/2016||Q316||($0.04)||($0.02)||$20.70 million||$20.05 million||View||Listen|
|8/3/2016||Q216||($0.05)||($0.05)||$19.88 million||$21.00 million||View||Listen|
|5/11/2016||Q116||($0.17)||($0.01)||$19.60 million||$19.30 million||View||Listen|
|3/2/2016||Q415||($0.02)||$0.01||$19.11 million||$20.90 million||View||Listen|
|10/28/2015||Q315||($0.04)||($0.04)||$17.87 million||$18.80 million||View||Listen|
|4/29/2015||Q115||($0.04)||$0.03||$17.85 million||$18.90 million||View||Listen|
|2/25/2015||Q414||($0.05)||($0.03)||$16.60 million||$16.60 million||View||Listen|
|10/30/2014||Q314||$0.02||($0.04)||$19.53 million||$18.20 million||View||Listen|
|7/30/2014||Q214||$0.03||$0.01||$19.80 million||$20.05 million||View||Listen|
|4/28/2014||Q114||$0.01||$0.04||$19.44 million||$20.20 million||View||Listen|
|2/26/2014||Q413||$0.02||$0.02||$18.98 million||$18.90 million||View||Listen|
|10/30/2013||Q313||$0.02||$0.04||$17.35 million||$17.10 million||View||Listen|
|7/31/2013||Q2 2013||$0.04||$0.05||$17.40 million||$18.20 million||View||Listen|
|5/1/2013||Q1 2013||$0.04||$0.08||$17.27 million||$18.00 million||View||Listen|
|2/27/2013||Q4 2012||$0.03||$0.01||$17.55 million||$16.50 million||View||Listen|
|10/31/2012||Q312||$0.01||$0.04||$16.78 million||$15.90 million||View||N/A|
Earnings Estimates for STAAR Surgical Company (NASDAQ:STAA)
Current Year EPS Consensus Estimate: $-0.03 EPS
Next Year EPS Consensus Estimate: $0.19 EPS
Dividend History for STAAR Surgical Company (NASDAQ:STAA)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for STAAR Surgical Company (NASDAQ:STAA)
Insider Ownership Percentage: 5.60%Insider Trades by Quarter for STAAR Surgical Company (NASDAQ:STAA)
Institutional Ownership Percentage: 76.54%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|12/9/2016||Hans-Martin Blickensdoerfer||VP||Sell||25,000||$11.14||$278,500.00|| |
|6/29/2016||Broadwood Partners Lp||Major Shareholder||Buy||14,144||$5.24||$74,114.56|| |
|5/25/2016||Broadwood Partners Lp||Major Shareholder||Buy||77,842||$5.16||$401,664.72|| |
|5/24/2016||Broadwood Partners Lp||Major Shareholder||Buy||70,000||$5.16||$361,200.00|| |
|5/23/2016||Broadwood Partners Lp||Major Shareholder||Buy||3,138||$5.24||$16,443.12|| |
|5/20/2016||Richard A Meier||Director||Sell||25,000||$5.35||$133,750.00|| |
|5/17/2016||Broadwood Partners Lp||Major Shareholder||Buy||9,313||$5.23||$48,706.99|| |
|5/16/2016||Broadwood Partners Lp||Major Shareholder||Buy||336,210||$5.49||$1,845,792.90|| |
|2/9/2016||Broadwood Partners Lp||Major Shareholder||Buy||91,770||$6.25||$573,562.50|| |
|2/3/2016||Broadwood Partners Lp||Major Shareholder||Buy||121,599||$6.40||$778,233.60|| |
|2/1/2016||Broadwood Partners Lp||Major Shareholder||Buy||65,983||$6.48||$427,569.84|| |
|1/27/2016||Broadwood Partners Lp||Major Shareholder||Buy||239,013||$6.63||$1,584,656.19|| |
|1/26/2016||Broadwood Partners Lp||Major Shareholder||Buy||112,900||$6.60||$745,140.00|| |
|1/25/2016||Broadwood Partners Lp||Major Shareholder||Buy||81,752||$6.74||$551,008.48|| |
|1/20/2016||Broadwood Partners Lp||Major Shareholder||Buy||72,858||$6.75||$491,791.50|| |
|1/15/2016||Broadwood Partners Lp||Major Shareholder||Buy||135,725||$6.73||$913,429.25|| |
|1/11/2016||Broadwood Partners Lp||Major Shareholder||Buy||86,586||$6.83||$591,382.38|| |
|1/7/2016||Broadwood Partners Lp||Major Shareholder||Buy||267,047||$6.95||$1,855,976.65|| |
|1/4/2016||Broadwood Partners Lp||Major Shareholder||Buy||165,461||$7.11||$1,176,427.71|| |
|9/29/2015||Broadwood Partners Lp||Major Shareholder||Buy||311,099||$7.08||$2,202,580.92|| |
|8/25/2015||Broadwood Partners Lp||Major Shareholder||Buy||188,881||$7.17||$1,354,276.77|| |
|8/24/2015||Caren L Mason||CEO||Buy||10,000||$7.34||$73,400.00|| |
|4/6/2015||Samuel J Gesten||VP||Sell||3,223||$7.14||$23,012.22|| |
|3/3/2015||Robin Hughes||VP||Sell||23,253||$15.82||$367,862.46|| |
|11/19/2014||Broadwood Partners Lp||Major Shareholder||Buy||189,646||$8.64||$1,638,541.44|| |
|11/18/2014||Broadwood Partners Lp||Major Shareholder||Buy||39,400||$8.67||$341,598.00|| |
|11/17/2014||Broadwood Partners Lp||Major Shareholder||Buy||118,200||$8.63||$1,020,066.00|| |
|11/10/2014||Broadwood Partners Lp||Major Shareholder||Buy||500||$8.79||$4,395.00|| |
|11/7/2014||Broadwood Partners Lp||Major Shareholder||Buy||80,000||$8.92||$713,600.00|| |
|11/4/2014||Broadwood Partners Lp||Major Shareholder||Buy||260,341||$9.20||$2,395,137.20|| |
|5/15/2014||John Moore||Director||Sell||2,800||$14.87||$41,636.00|| |
|3/19/2014||James Francese||VP||Sell||16,666||$17.22||$286,988.52|| |
|3/17/2014||Robin Hughes||VP||Sell||5,672||$16.61||$94,211.92|| |
|9/4/2013||Deborah Andrews||CFO||Sell||50,000||$12.88||$644,000.00|| |
|8/20/2013||Deborah Andrews||CFO||Sell||33,515||$11.65||$390,449.75|| |
|8/12/2013||Deborah Andrews||CFO||Sell||9,079||$11.62||$105,497.98|| |
|8/7/2013||Deborah Andrews||CFO||Sell||11,721||$11.79||$138,190.59|| |
|5/9/2013||Deborah J Andrews||CFO||Sell||5,000||$8.96||$44,800.00|| |
|12/11/2012||John C Moore||Director||Buy||5,000||$5.46||$27,300.00|| |
|11/15/2012||Broadwood Partners Lp||Major Shareholder||Buy||2,618||$5.00||$13,090.00|| |
|11/15/2012||Mark B Logan||Director||Buy||3,600||$5.22||$18,792.00|| |
|11/14/2012||Barry G Caldwell||CEO||Buy||5,000||$5.04||$25,200.00|| |
|11/2/2012||Broadwood Partners Lp||Major Shareholder||Buy||22,572||$5.00||$112,860.00|| |
|8/9/2012||Barry G Caldwell||CEO||Buy||5,000||$6.57||$32,850.00|| |
Headline Trends for STAAR Surgical Company (NASDAQ:STAA)
Latest Headlines for STAAR Surgical Company (NASDAQ:STAA)
Loading headlines, please wait.
STAAR Surgical Company (STAA) Chart for Monday, October, 23, 2017